Pinnacle Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pinnacle Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$20K	Buy	+1,000	New	+$18.8K	﹤0.01%	440

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pinnacle Wealth Advisors's AMPH Position: Q2 2021 in Review

Pinnacle Wealth Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2021: 1,000 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #440 among its holdings.

146 funds tracked by Wall St. Rank hold AMPH as of Q2 2021.

Pinnacle Wealth Advisors held 1,000 shares of Amphastar Pharmaceuticals worth $20K as of Q2 2021.
Amphastar Pharmaceuticals was a new Pinnacle Wealth Advisors position in Q2 2021.
Amphastar Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Advisors's portfolio in Q2 2021, its #440 holding.
146 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2021.

Based on Pinnacle Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.